Some Democrats in Washington are calling for an investigation into the circumstances surrounding former FDA Chairman Lester Crawford's abrupt resignation last week. Speculation has centered on the possibility that a potential financial conflict of interest was involved. Yesterday, the ex-chairman denied those reports, telling Forbes that his decision to depart was a result of burnout from the day-to-day stress of managing the agency at a time when it has been under fire over its handling of drug safety and other regulatory issues.
- see this article from the Boston Globe
- see this article from Forbes.com